BioSpace News Archive

Business

Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies

Gilead Sciences, Inc. and Carna Biosciences Inc. announced that the companies have entered into a research and development collaboration to develop and commercialize small molecule compounds in immuno-oncology and to access Carna’s proprietary lipid kinase drug discovery platform.

June 24, 2019
·
4 min read
Business

BioEclipse Therapeutics™ Announces Appointment of New Directors and Series A-1 Financing

$9.3 million raised to date; latest funding to be used to advance lead immunotherapy, CRX-100, into Phase 1b/2a clinical trials in therapy-refractory solid tumors

June 24, 2019
·
6 min read
Deals

AFYX Therapeutics Closes $13 Million Convertible Loan Financing

Funds support the completion of ongoing Phase 2b study in Oral Lichen Planus

June 24, 2019
·
2 min read
FDA

Micro Medical Solutions Receives FDA IDE Approval for Pivotal Clinical Trial of MicroStent

Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced today that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA)

June 24, 2019
·
4 min read
Deals

Phreesia Files Registration Statement for Initial Public Offering

Phreesia announced it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of shares of its common stock.

June 24, 2019
·
2 min read
Biotech Beach

New Study Uses Masimo SedLine® Brain Function Monitoring to Assess the Prevalence of Isoelectric EEG Events in Infants and Young Children Undergoing General Anesthesia

Masimo (NASDAQ: MASI) announced today that in a study recently published in Anesthesia & Analgesia, researchers investigated the incidence of isoelectric electroencephalogram (EEG) events in infants and young children undergoing scheduled surgery requiring general anesthesia.

June 24, 2019
·
9 min read
Policy

CMS Decision on TAVR Puts Patients at the End of the Line, says Heart Valve Voice

The Centers for Medicaid and Medicare Services last Friday issued their final National Coverage Decision on how hospitals will be approved to do the TAVR procedure, a less invasive valve replacement treatment that avoids open heart surgery and allows patients to resume daily life more quickly.

June 24, 2019
·
1 min read
BioMidwest

Vireo Health to Present at MJ Micro Conference in New York on June 25

Vireo Health International, Inc. (“Vireo” or the “Company”) (CSE: VREO), a leading science-focused, multi-state cannabis company, today announced its participation at the MJ Micro Conference in New York City on June 25, 2019.

June 24, 2019
·
1 min read
Business

Avellino Labs Founder Gene Lee Receives 2019 Ellis Island Medal of Honor, Named to World Economic Forum’s Precision Medicine Council

Avellino Labs, a global biotechnology and genetic science innovator, announced today the company’s founder, chairman and president, Gene Lee, is a recipient of a 2019 Ellis Island Medal of Hono

June 24, 2019
·
3 min read
MedX Health Signs Distribution Agreement for Canada, USA and Israel

MedX Health Corp. (“MedX”) (TSX-V: MDX) announces that it has signed a non-exclusive, performance-based distribution agreement with Group Vida, to distribute MedX’s DermSecureTM skin cancer assessment technology platform in the USA, Canada and Israel.

June 24, 2019
·
4 min read